A novel mammalian cell (Vero) derived influenza virus vaccine: Development, characterization and industrial scale production

Wiener Klinische Wochenschrift

Volumn 111, Issue 5, 1999, Pages 207-214

  Kistner, Otfried ^a   Barrett, P Noel ^a   Mundt, Wolfgang ^a   Reiter, Manfred ^a   Schober Bendixen, Susanne ^a   Eder, Gerald ^a   Dorner, Friedrich ^a  

^a BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

Influenza vaccine; Serum free; Vero cell

Indexed keywords

EGG PROTEIN; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; OVALBUMIN;

ALLERGY; ANIMAL CELL; ARTICLE; BIOREACTOR; CHICK EMBRYO; CHIMPANZEE; CONTROLLED STUDY; DRUG CONTAMINATION; DRUG PURIFICATION; DRUG SAFETY; EGG; FERRET; HEMAGGLUTINATION INHIBITION; IMMUNOGENICITY; MAMMAL CELL; NONHUMAN; VACCINE PRODUCTION; VERO CELL;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CULTURE MEDIA, SERUM-FREE; EGGS; FERRETS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE INFECTIONS; PAN TROGLODYTES; VACCINES, SYNTHETIC; VERO CELLS; VIRAL VACCINES;

EID: 0033548645     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rowe PM (1995) Pandemic influenza (un)preparedness described. Lancet 346: 1699
2. Petricciani JC (1991) Regulatory philosophy and acceptability of cells for the production of biologicals. Dev Biol Stand 75: 9-15
3. Schild GC, Oxford JS, De Jong JC, Webster RG (1983) Evidence for host-cell selection of influenza virus antigenic variants. Nature 303: 706-709
4. Robertson JS, Bootman JS, Newman R, Oxford JS, Daniels RS, Webster RG, et al (1987) Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 160: 31-37
5. Hardy CT, Young SA, Webster RG, Naeve CW, Owens RF (1995) Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of Influenza A (H3N2) virus. Virology 211: 302-306
6. Katz JM, Webster RG (1988) Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. Virology 165: 446-456
7. Robertson JS (1993) Clinical influenza virus and the embryonated hen's egg. Rev Med Virol 3: 97-106
8. Katz JM, Webster RG (1989) Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 160: 191-198
9. Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS (1989) Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171: 214-221
10. Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting (1995) Bull WHO 73: 431-435
11. Montagnon BJ, Fanget B, Nicholas AJ (1981) The largescale cultivation of Vero cells in microcarrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev Biol Stand 47: 55-64
12. Nakamura K, Homma M (1981) Protein synthesis in Vero cells abortively infected with Influenza B virus. J Gen Virol 56: 199-202
13. Lau SC, Scholtissek C (1995) Abortive infection of Vero cells by an Influenza A virus (FPV). Virology 212: 225-231
14. Govorkova EA, Murti G, Meignier B, De Taisne C, Webster RG (1996) African Green Monkey Kidney (Vero) cells provide an alternative host cell system for Influenza A and B virus. J Virol 70: 5519-5524
15. Wood JM, Schild GC, Newman RW, Seagroatt V (1977) An improved single-radial-irnmunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand 5: 237-247
16. Cavalli Sforza L (1972) Biometrie - Grundzüge biologisch-medizinischer Statistik, 3. Aufl., Fischer, Stuttgart, S 159-186
17. Committee for Proprietary Medicinal Products (CPMP) (1996) Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96), 17 July 1996, pp 20-21
18. European Pharmacopoeia (1997) 3rd edn. 0159 (1-4) Influenza Vaccine (whole virion, inactivated)
19. FDA (1993) Points to consider in the characterization of cell lines used to produce biologicals.
20. Murphy BR, Webster RG (1996) Orthomyxoviruses. In: Field BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds) Fields virology, vol 1, 3rd edn Lippincott-Raven, Philadelphia, pp 1307-1446.
21. Lazarowitz SG, Choppin PW (1975) Enhancement of the infectivity of Influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440-454
22. Rott R, Reinacher M, Orlich M, Klenk HD (1980) Cleavability of hemagglutinin determines spread of avian influenza viruses in the chorioallantoic membrane of chicken embryo. Arch Virol 65: 123-133
23. Klenk HD, Rott R, Orlich M, Blödorn J (1975) Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439
24. Stienecke-Gröber A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W (1992) Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO 11: 2407-2414
25. Govorkova EA, Kaverin NV, Gubareva LV, Meignier B, Webster RG (1995) Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J Infect Dis 172: 250-253
26. Kaverin NV, Webster RG (1995) Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol 69: 2700-2703